Optimal process mode selection for clone screening.

Area of Science:

• Biotechnology
• Biopharmaceutical Manufacturing
• Cell Line Development

Background:

• Clone screening generates vast datasets from diverse cultivation systems like well-plates and bioreactors.
• Statistical and data mining methods are essential for extracting meaningful information from large datasets.
• Monoclonal antibody (mAb) production relies heavily on efficient clone selection for optimal yield and quality.

Purpose of the Study:

• To evaluate the equivalence of clone selection based on initial batch data versus fed-batch data in a biosimilar mAb project.
• To determine the optimal timing for implementing fed-batch processes during clone screening.
• To assess the impact of process type (batch vs. fed-batch) on clone selection outcomes.

Main Methods:

• Comparison of batch and fed-batch cultivation processes at the shake-flask scale.
• Analysis of data from multiple clones derived from two distinct cell lines.
• Statistical analysis of cultivation parameters and product quality attributes.

Main Results:

• Clone selection based on batch data showed divergent results compared to selection based on fed-batch data.
• Significant differences were observed in clone performance between batch and fed-batch conditions.
• The study highlights the critical influence of process mode on clone selection outcomes.

Conclusions:

• Fed-batch processes should be integrated early in the screening procedure if the final manufacturing process is intended to be fed-batch.
• Relying solely on batch data for clone selection can lead to suboptimal choices for fed-batch manufacturing.
• Early adoption of fed-batch screening ensures alignment between development and manufacturing processes for biosimilar mAb production.